FDA Considering Latuda for the Treatment of Bipolar Disorder

A recent article in the Boston Business Journal notes that the FDA is considering Sunovion Pharmaceuticals Inc.’s requests to approve recent drug Latuda for use in treating bipolar disorder.

Currently, Latuda is only approved for the treatment of schizophrenia, but one application is requesting it be approved to be used in conjunction with other medications to treat bipolar disorder, and another application requests it be approved to treat bipolar disorder alone.

If you aren’t familiar with Latuda (Lurasidone), it is an atypical psychotic approved by the FDA for the treatment of schizophrenia in 2010.

Looking at the list of side effects, they look comparable to those of Geodon (which I just started recently). Side effects range from things like uncontrollable muscle movements, insomnia, nausea, drowsiness, and agitation.

I know this drug has not actually been approved by the FDA for bipolar disorder yet, but I do know one or two people that have been taking it for bipolar symptoms. For those of us who have symptoms bordering on schizophrenia (or schizoaffective disorder) or for those who haven’t been able to tolerate other atypical antipsychotics (like abilify, zyprexa, or geodon) it is always great to hear that there may soon be another option out there!

Advertisements

One response to “FDA Considering Latuda for the Treatment of Bipolar Disorder

  1. Pingback: Latuda Approved by FDA For Some Bipolar Cases | bi[polar] curious

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s